Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026

Summary by AI BETAClose X

Vivoryon Therapeutics N.V. announced that it will report its first quarter financial results for the period ending March 31, 2026, on June 11, 2026. The company, which is developing small molecule medicines for inflammatory and fibrotic disorders, particularly kidney diseases, also indicated that its next financial and business update conference call and webcast will occur in August, coinciding with the publication of its H1 results.

Disclaimer*

UK 100

Latest directors dealings